The main blood sugar monitors that work without routine finger pricks are continuous glucose monitors (CGMs). The leading options in the US are Dexcom G7, Abbott FreeStyle Libre 3 and Libre 2 Plus, and Medtronic Guardian. They use a small filament inserted under the skin to measure interstitial glucose every 1 to 5 minutes, send readings wirelessly to your phone or receiver, and last 10 to 15 days per sensor. Newer over-the-counter options like Dexcom Stelo, Abbott Lingo, and FreeStyle Libre Rio are now available for adults without diabetes.
How CGMs Work
A CGM has three parts:
- Sensor: A flexible filament about the thickness of a hair, inserted just under the skin (usually on the upper arm or abdomen). It measures glucose in the interstitial fluid between cells.
- Transmitter: Sits on top of the sensor and wirelessly sends data, usually via Bluetooth.
- Display: A smartphone app, dedicated receiver, or smartwatch shows current glucose, a trend arrow (up, down, steady), and a graph of the last hours.
Interstitial glucose lags blood glucose by 5 to 15 minutes, especially during rapid changes. CGMs use mathematical correction to align readings with blood values. Modern devices achieve a Mean Absolute Relative Difference (MARD) of 8 to 10% — comparable to or better than home fingerstick meters.
The Major CGM Options
Dexcom G7
- Wear time: 10 days plus a 12-hour grace period
- Warm-up: 30 minutes (fastest on the market)
- Calibration: Factory-calibrated; no finger sticks required
- Reading frequency: Every 5 minutes
- Wear site: Back of upper arm (adults), upper buttock (children 2+)
- Water resistance: Showering, swimming OK to 8 feet for 24 hours
- Smartwatch: Direct-to-Apple-Watch streaming
- Best for: Type 1 diabetes, insulin-using type 2, anyone wanting strong app integration
Abbott FreeStyle Libre 3
- Wear time: 14 days
- Warm-up: 60 minutes
- Calibration: Factory-calibrated
- Reading frequency: Every 1 minute (most frequent of any CGM)
- Wear site: Back of upper arm
- Water resistance: 30 minutes at 3 feet
- Form factor: Smallest CGM available — coin-sized, low profile
- Best for: Cost-sensitive users, people who want the smallest sensor
FreeStyle Libre 2 Plus
- 14-day wear, optional alarms, slightly larger sensor than Libre 3
- Compatible with select insulin pumps (iLet, Tandem t:slim X2)
Medtronic Guardian 4
- Wear time: 7 days
- Warm-up: 2 hours
- Calibration: No fingersticks required for treatment decisions
- Best for: Users of Medtronic insulin pumps (MiniMed 780G with automated insulin delivery)
Eversense E3 (Implantable)
- Wear time: Up to 180 days (a clinician implants the sensor in an office procedure)
- Calibration: Twice-daily fingersticks required
- Best for: Patients who dislike weekly sensor changes
Over-the-Counter CGMs (No Prescription)
In 2024 the FDA approved the first OTC CGMs aimed at adults who do not use insulin, including people with type 2 diabetes managed by lifestyle and metformin, and people without diabetes interested in metabolic data.
Dexcom Stelo
- 15-day wear, factory-calibrated, glucose updates every 15 minutes
- For adults 18+ not using insulin
- Around $89/month direct from Dexcom
Abbott Lingo
- 14-day wear, glucose readings every minute
- Marketed for general wellness, with coaching content
- Around $89/month with subscription
FreeStyle Libre Rio
- OTC version of Libre, similar specs to Libre 2 Plus
- For adults 18+ not on insulin
Comparison Table
| System | Wear Time | Warm-up | Update Frequency | Prescription | Approx Monthly Cost (cash) |
|---|---|---|---|---|---|
| Dexcom G7 | 10 days + 12 hr | 30 min | 5 min | Yes | $300-350 |
| FreeStyle Libre 3 | 14 days | 60 min | 1 min | Yes | $140-180 |
| FreeStyle Libre 2 Plus | 14 days | 60 min | 1 min | Yes | $140-180 |
| Medtronic Guardian 4 | 7 days | 2 hr | 5 min | Yes | $300+ |
| Eversense E3 | 180 days (implanted) | 24 hr | 5 min | Yes | ~$300/mo equivalent |
| Dexcom Stelo | 15 days | 30 min | 15 min | OTC | $89 |
| Abbott Lingo | 14 days | 60 min | 1 min | OTC | $89 |
| FreeStyle Libre Rio | 14 days | 60 min | 1 min | OTC | $89 |
Pros and Cons of CGMs
Pros
- No routine finger pricks
- Continuous data shows trends, not just snapshots
- Predictive low-glucose alerts can prevent severe hypoglycemia
- Reveals food and exercise effects you would otherwise miss
- Time-in-range metric is a better outcome measure than A1C alone
- Shareable data with family and clinicians
- Reduces diabetes distress in many users
Cons
- Cost — even with insurance, copays can be substantial
- Skin reactions to adhesive in some users
- Sensor failures and accuracy issues, especially in the first 12-24 hours
- Alarm fatigue if alerts are too sensitive
- Anxiety from constant data — not everyone benefits psychologically
- Some MRI and CT scans require sensor removal
Insurance Coverage
Coverage has expanded dramatically. Current rules of thumb:
- Medicare: Covers CGMs for all insulin-treated diabetes (type 1 or type 2 on any insulin) and for problematic hypoglycemia even without insulin.
- Medicaid: Coverage varies by state but expanding.
- Commercial insurance: Most plans cover CGMs for type 1 and insulin-using type 2 diabetes; many now cover them for non-insulin users with elevated A1C.
- Pharmacy vs DME: Most major CGMs are now available through pharmacy benefits, eliminating the durable medical equipment paperwork.
Call your insurer or use the manufacturer’s online benefits checker before ordering.
Non-Diabetic Use
Many people without diabetes use CGMs to:
- See how specific foods affect their glucose
- Optimize meal timing and composition
- Track effects of exercise, sleep, and stress
- Identify reactive hypoglycemia
- Catch early signs of insulin resistance
Evidence that CGM use improves outcomes in non-diabetic adults is still emerging. Glucose values in healthy people stay within a tighter range than many wellness apps suggest, so do not over-interpret modest swings. If you find values regularly above 140 mg/dL after meals or fasting above 100 mg/dL, talk with your doctor and consider a formal glucose tolerance test or A1C — see our guide to normal A1C ranges.
Time-in-Range: A New Standard
The major benefit of CGM is the time-in-range (TIR) metric — the percentage of the day spent between 70 and 180 mg/dL. Targets:
- Most adults with diabetes: > 70% time in range, < 4% below 70 mg/dL
- Older or high-risk adults: > 50% time in range, < 1% below 70 mg/dL
- Pregnancy with type 1 diabetes: > 70% in 63-140 mg/dL range
TIR correlates well with A1C and may better predict complications because it accounts for glucose variability that A1C misses.
How to Get Started
- Talk with your doctor about whether CGM is right for you
- Check insurance coverage (manufacturer websites have benefit checkers)
- Get a prescription, or order an OTC sensor directly
- Watch the manufacturer’s setup video before applying your first sensor
- Apply sensor, wait through warm-up, and start logging meals and activity
- Review trends with your healthcare provider monthly at first
The Bottom Line
The best blood sugar monitors that skip finger pricks are continuous glucose monitors. Dexcom G7 and FreeStyle Libre 3 lead the prescription market with factory calibration, no required finger sticks, and excellent app integration. Medtronic Guardian 4 pairs with their automated insulin pump. Over-the-counter Stelo, Lingo, and Libre Rio bring CGM to non-insulin users for around $89 a month. Whether you have type 1, type 2, prediabetes, or no diabetes at all, CGMs can reveal glucose patterns that help you make smarter decisions about food, exercise, sleep, and stress. Discuss the right option with your healthcare team and confirm insurance coverage before ordering, and remember that the value of a CGM lies in how you use the data — not the device itself.
